Talea Group SpA (FRA:U5Y) ROE %: -8.35% (As of Dec. 2024)


FRA:U5Y Talea Group SpA FRA:U5Y
8 GF Score
Price €4.45
View Full Analysis

What is Talea Group SpA ROE %?

Talea Group SpA FRA:U5Y 8 ROE % is -8.35% as of Dec. 2024. GuruFocus rates FRA:U5Y with a GF Score™ of 8/100.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Talea Group SpA's annualized net income for the quarter that ended in Dec. 2024 was €-2.7 Mil. Talea Group SpA's average Total Stockholders Equity over the quarter that ended in Dec. 2024 was €31.9 Mil. Therefore, Talea Group SpA's annualized ROE % for the quarter that ended in Dec. 2024 was -8.35%.

The historical rank and industry rank for Talea Group SpA's ROE % or its related term are showing as below:

FRA:U5Y's ROE % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 5.72
* Ranked among companies with meaningful ROE % only.

Talea Group SpA  (FRA:U5Y) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2024 )
=Net Income/Total Stockholders Equity
=-2.668/31.9405
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-2.668 / 106.29)*(106.29 / 141.0875)*(141.0875 / 31.9405)
=Net Margin %*Asset Turnover*Equity Multiplier
=-2.51 %*0.7534*4.4172
=ROA %*Equity Multiplier
=-1.89 %*4.4172
=-8.35 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2024 )
=Net Income/Total Stockholders Equity
=-2.668/31.9405
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-2.668 / -3.982) * (-3.982 / -1.3) * (-1.3 / 106.29) * (106.29 / 141.0875) * (141.0875 / 31.9405)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.67 * 3.0631 * -1.22 % * 0.7534 * 4.4172
=-8.35 %

Note: The net income data used here is two times the semi-annual (Dec. 2024) net income data. The Revenue data used here is two times the semi-annual (Dec. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Talea Group SpA ROE % Related Terms


Talea Group SpA ROE % Historical Data

* Premium members only.

The historical data trend for Talea Group SpA's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Talea Group SpA ROE % Chart

Talea Group SpA Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE %
Get a 7-Day Free Trial -10.33 -0.37 -2.38 -21.27 -9.88

Talea Group SpA Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.72 -4.80 -37.64 -12.72 -8.35

Talea Group SpA ROE % Competitor Comparison

For the Pharmaceutical Retailers subindustry, Talea Group SpA's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Talea Group SpA ROE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Talea Group SpA's ROE % distribution charts can be found below:

* The bar in red indicates where Talea Group SpA's ROE % falls into.


FRA:U5Y
8GF Score
Talea Group SpA FRA:U5Y
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Talea Group SpA ROE % Calculation

Talea Group SpA's annualized ROE % for the fiscal year that ended in Dec. 2024 is calculated as

ROE %=Net Income (A: Dec. 2024 )/( (Total Stockholders Equity (A: Dec. 2023 )+Total Stockholders Equity (A: Dec. 2024 ))/ count )
=-3.248/( (31.052+34.707)/ 2 )
=-3.248/32.8795
=-9.88 %

Talea Group SpA's annualized ROE % for the quarter that ended in Dec. 2024 is calculated as

ROE %=Net Income (Q: Dec. 2024 )/( (Total Stockholders Equity (Q: Jun. 2024 )+Total Stockholders Equity (Q: Dec. 2024 ))/ count )
=-2.668/( (29.174+34.707)/ 2 )
=-2.668/31.9405
=-8.35 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Dec. 2024) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of -8.35% mean?
Talea Group SpA (FRA:U5Y) has a ROE % of -8.35% as of Dec. 2024. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Talea Group SpA and its competitors.
Is Talea Group SpA's ROE % too high?
Talea Group SpA's current ROE % is -8.35%. Overall, Talea Group SpA has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Talea Group SpA's ROE % compare to competitors?
Talea Group SpA's ROE % of -8.35% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROE % is 5.72. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.72, based on 628 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Talea Group SpA and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Talea Group SpA's current ROE % is -8.35%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Talea Group SpA stock overvalued right now?
Talea Group SpA (FRA:U5Y) has a current ROE % of -8.35%. The current ROE % is -8.35%. Talea Group SpA's overall GF Score™ is 8/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Talea Group SpA (FRA:U5Y), the current ROE % is -8.35% as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Talea Group SpA Business Description

Address Via Aurelia Nord 141, Viareggio, ITA, 55049
Talea Group SpA is an online retailer of heath and wellness products in Italy. The product categories of the company include over-the-counter drugs; orthopedics and aids; homeopathic products; para pharmaceuticals; medical devices; products for children; herbal; diet products and pet products among others.
8GF Score

Get the complete analysis for FRA:U5Y

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.45
Price